(Q48211230)

9 February 2018

title

Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. (English)

1 reference

9 February 2018

chronic renal insufficiency

0 references

1 reference

1 reference

inferred from title

author

Vasilios Papademetriou

1

1 reference

9 February 2018

ACCORD Study Group

11

object named as

ACCORD Study Group

1 reference

9 February 2018

author name string

Laura Lovato

2

1 reference

9 February 2018

Michael Doumas

3

1 reference

9 February 2018

Eric Nylen

4

1 reference

9 February 2018

Amy Mottl

5

1 reference

9 February 2018

Robert M Cohen

6

1 reference

9 February 2018

William B Applegate

7

1 reference

9 February 2018

Zubin Puntakee

8

1 reference

9 February 2018

Jean Francois Yale

9

1 reference

9 February 2018

William C Cushman

10

1 reference

9 February 2018

language of work or name

English

0 references

publication date

17 September 2014

1 reference

9 February 2018

published in

Kidney International

1 reference

9 February 2018

volume

87

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

649-659

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/ki.2014.296

exact match

0 references

cites work

Temporal trends in the prevalence of diabetic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Prevalence of chronic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

CKD and mortality risk in older people: a community-based population study in the United Kingdom

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Glomerular Filtration Rate, Cardiorenal End Points, and All-Cause Mortality in Type 2 Diabetic Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Point: Intensive glycemic control and mortality in ACCORD--a chance finding?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Chronic kidney disease as cause of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

The prognostic significance of proteinuria: the Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Frequency of hypoglycemia and its significance in chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Drug dosing in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Death during intensive glycemic therapy of diabetes: mechanisms and implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Effects of intensive blood-pressure control in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.296

7 January 2021

Identifiers

DOI

10.1038/KI.2014.296

1 reference

9 February 2018

1 reference

9 February 2018